STOCK TITAN

Executive equity grants and tax withholdings at TELA Bio (NASDAQ: TELA) detailed

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

TELA Bio, Inc. Chief Business Officer Gregory A. Firestone reported a mix of equity grants and tax-related share dispositions. On February 20, 2026, he was granted 55,000 stock options and 37,000 shares of common stock in the form of restricted stock units that vest in four equal annual installments beginning February 20, 2027, subject to his continued service. The option vests 25% on February 20, 2027, with the remaining 75% vesting in equal monthly installments over the next 36 months, also conditioned on continued service. On February 21 and 23, 2026, a total of 5,541 common shares were withheld by the company at prices of $0.7174 and $0.7660 per share to satisfy tax liabilities upon RSU vesting, leaving him with 139,307 common shares held directly, which includes 1,058 shares acquired under the employee stock purchase plan.

Positive

  • None.

Negative

  • None.
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Firestone Gregory A.

(Last) (First) (Middle)
C/O TELA BIO, INC.
1 GREAT VALLEY PARKWAY, SUITE 24

(Street)
MALVERN PA 19355

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
TELA Bio, Inc. [ TELA ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Chief Business Officer
3. Date of Earliest Transaction (Month/Day/Year)
02/20/2026
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 02/20/2026 A 37,000(1) A $0 144,848(2) D
Common Stock 02/21/2026 F 4,189(3) D $0.7174 140,659 D
Common Stock 02/23/2026 F 1,352(3) D $0.766 139,307 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Option (Right to Buy) $0.717 02/20/2026 A 55,000 (4) 02/20/2036 Common Stock 55,000 $0 55,000 D
Explanation of Responses:
1. These restricted stock units ("RSUs") will vest in four equal annual installments beginning on February 20, 2027, subject to the Reporting Person's continuous service through the applicable vesting dates.
2. Includes 1,058 shares acquired under the Company's employee stock purchase plan on January 30, 2026.
3. Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of RSUs.
4. The option vests 25% on February 20, 2027, with the remaining 75% vesting in equal monthly installments on the last day of each of the 36 calendar months immediately following such date, subject to the Reporting Person's continued service through the applicable vesting dates.
/s/ Megan Smeykal, Attorney-in-Fact 02/24/2026
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What equity awards did TELA (TELA) executive Gregory Firestone receive?

Gregory A. Firestone received a grant of 55,000 stock options and 37,000 shares of common stock in the form of restricted stock units, all awarded on February 20, 2026, subject to multi-year vesting and his continued service with TELA Bio, Inc.

How do Gregory Firestone’s new TELA (TELA) restricted stock units vest?

The restricted stock units granted to Gregory A. Firestone vest in four equal annual installments beginning on February 20, 2027. Each installment requires his continuous service with TELA Bio, Inc. through the applicable vesting date, spreading the vesting over a total of four years.

What is the vesting schedule for Gregory Firestone’s 55,000 TELA stock options?

The 55,000 stock options vest 25% on February 20, 2027. The remaining 75% then vest in equal monthly installments over the following 36 months, with each portion requiring Gregory A. Firestone’s continued service through the respective vesting dates.

Were Gregory Firestone’s recent TELA (TELA) share dispositions open-market sales?

No, the reported dispositions were not open-market sales. A total of 5,541 common shares were withheld by TELA Bio to satisfy applicable withholding taxes upon vesting of restricted stock units, classified as tax-withholding dispositions rather than discretionary share sales.

How many TELA Bio shares does Gregory Firestone hold after these transactions?

Following the reported transactions, Gregory A. Firestone directly holds 139,307 shares of TELA Bio common stock. This figure includes 1,058 shares that were acquired earlier under the company’s employee stock purchase plan on January 30, 2026.

What role does Gregory Firestone hold at TELA (TELA) in this Form 4 filing?

In this Form 4, Gregory A. Firestone is identified as an officer of TELA Bio, Inc., serving as the Chief Business Officer. The reported equity grants and tax-withholding share dispositions relate to his compensation and ongoing service in that executive position.
Tela Bio, Inc.

NASDAQ:TELA

TELA Rankings

TELA Latest News

TELA Latest SEC Filings

TELA Stock Data

34.11M
40.80M
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States
MALVERN